/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Allos Therapeutics Inc. (ALTH) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 6.959\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 0.019\n\n (+0.27%)\n\n \n\n \n\n \n\n \n\n Volume: 7.35 k\n\n \n\n \n\n\n\n 9:33 AM EST Feb 10, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
September 22,2009
\n \n
Close: \n 8.79\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
April 14,2009
\n \n
Close: \n 5.34\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
6.959
\n 		\n\n \n \n \n
Change $
\n \n 0.019\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 0.27%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
6.94
\n 		\n \n \n \n\n
Bid Size
100
\n 		\n \n \n \n
Ask
6.96
\n\n 		\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
6.91
\n 		\n \n \n \n
High
6.96
\n 		\n\n \n \n \n
Low
6.90
\n 		\n \n\n \n \n
Prev Close
6.94
\n
\n \n\n \n \n
Last Trade
9:33
\n 		\n \n \n \n
Volume
7.35 k
\n 		\n \n \n \n
\n
52 Wk Hi
8.79
\n 		\n\n \n \n \n
52 Wk Low
5.34
\n
\n \n\n \n \n
Market Cap
723.33 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
103,941,015
\n 		\n \n \n \n
EPS (TTM)
-0.78
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
NASDAQ (NSD)
\n
\n
\n
\n
\n
\n \n
Exchange
NSD
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Allos Therapeutics Inc.\n\n \n\n  (ALTH) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for ALTH\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Feb 03, 2010
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics to Present at BIO CEO & Investor Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jan 06, 2010
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics to Present at J.P. Morgan Healthcare Conference - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 11, 2009
\n\n \n\n\n\n
6:26 AM\n\n\n\n Wall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key Players - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 08, 2009
\n\n \n\n\n\n
9:15 AM\n\n\n\n Allos Therapeutics' FOLOTYN(TM) Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma - Business Wire
6:52 AM\n\n\n\n Stock Watch: StockPreacher.com Issues Market Alert for Allos Therapeutics Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Dec 07, 2009
\n\n \n\n\n\n
10:00 AM\n\n\n\n Allos Therapeutics' FOLOTYN(TM) Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Sun, Dec 06, 2009
\n\n \n\n\n\n
2:19 AM\n\n\n\n New drug for rare cancer $30,000 a month - UPI
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Sat, Dec 05, 2009
\n\n \n\n\n\n
10:00 AM\n\n\n\n Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN(TM) at 51st ASH Annual Meeting - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 04, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN(TM) (pralatrexate injection) - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 03, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 30, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 23, 2009
\n\n \n\n\n\n
6:39 AM\n\n\n\n Ridgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn Energy LLC, Intel Corp. and Allos Therapeutics Inc. - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 11, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics Announces New Data on FOLOTYN(TM) to be Presented at the American Society of Hematology Meeting - Business Wire
6:55 AM\n\n\n\n AnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOP - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 10, 2009
\n\n \n\n\n\n
9:51 AM\n\n\n\n Allos Therapeutics to Present at Upcoming Conferences in November - Business Wire
9:12 AM\n\n\n\n NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 03, 2009
\n\n \n\n\n\n
4:01 PM\n\n\n\n Allos Therapeutics Reports Third Quarter 2009 Financial Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Nov 02, 2009
\n\n \n\n\n\n
5:28 AM\n\n\n\n New Shire Board Member - PR Newswire
5:16 AM\n\n\n\n Global Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.com - Marketwire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Oct 26, 2009
\n\n \n\n\n\n
8:00 AM\n\n\n\n Allos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009 - Business Wire
\n\n More News for ALTH >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");